Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,141,489 papers from all fields of science
Search
Sign In
Create Free Account
Resectable Cholangiocarcinoma
A cholangiocarcinoma that is amenable to surgical resection.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
12 relations
Abdominal Pain
Bile Duct Epithelium
Bile duct structure
Biliary tract structure
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
The effect of adjuvant chemotherapy in resectable cholangiocarcinoma: A meta-analysis and systematic review.
Mingliang Wang
,
Z. Ke
,
Shuai Yin
,
Chen-hai Liu
,
Qiang Huang
Hepatobiliary & Pancreatic Diseases International
2019
Corpus ID: 53721717
2018
2018
Diagnostic and Prognostic Role of 18-FDG PET/CT in the Management of Resectable Biliary Tract Cancer
K. Ma
,
T. Cheung
,
+5 authors
C. Lo
World Journal of Surgery
2018
Corpus ID: 3274214
ObjectivesRole of 18-FDG PET/CT had been well established in other more prevalent malignancies such as colorectal and lung cancer…
Expand
2016
2016
Impact of adjuvant chemoradiation on survival in patients with resectable cholangiocarcinoma.
L. Dover
,
R. Oster
,
A. McDonald
,
D. Dubay
,
Thomas Wang
,
R. Jacob
HPB
2016
Corpus ID: 25191288
2015
2015
Increased absorbed liver dose in Selective Internal Radiation Therapy (SIRT) correlates with increased sphere-cluster frequency and absorbed dose inhomogeneity
Jonas Högberg
,
M. Rizell
,
+5 authors
P. Bernhardt
EJNMMI Physics
2015
Corpus ID: 18880624
BackgroundThe higher tolerated mean absorbed dose for selective internal radiation therapy (SIRT) with intra-arterially infused…
Expand
2015
2015
Bilateral ovarian metastasis from distal common bile duct carcinoma developing after choledochal cyst excision
Seung Eun Lee
,
Y. Choi
,
M. K. Kim
,
Hyoung-Chul Oh
,
J. Do
Korean Journal of Hepato-Biliary-Pancreatic…
2015
Corpus ID: 8298871
Ovarian metastases represent about 3-5% of all ovarian malignancies. Most of these tumors originate in the digestive tract and…
Expand
2013
2013
Adjuvant chemotherapy in resectable cholangiocarcinoma patients
K. Wirasorn
,
T. Ngamprasertchai
,
+4 authors
A. Sookprasert
Journal of Gastroenterology and Hepatology
2013
Corpus ID: 23634592
Cholangiocarcinoma patients usually have poor treatment outcome and a high mortality rate. The role of adjuvant chemotherapy (AC…
Expand
2013
2013
Prognostic factors in resectable cholangiocarcinoma patients: Carcinoembryonic antigen, lymph node, surgical margin and chemotherapy.
K. Wirasorn
,
T. Ngamprasertchai
,
+4 authors
P. Ungarereevittaya
World Journal of Gastrointestinal Oncology
2013
Corpus ID: 30129245
AIM To evaluate outcomes in resectable cholangiocarcinoma patients and to determine prognostic factors. METHODS A retrospective…
Expand
Review
2008
Review
2008
Survival and an overview of decision-making in patients with cholangiocarcinoma.
H. M. Forsmo
,
A. Horn
,
A. Viste
,
D. Hoem
,
K. Ovrebo
Hepatobiliary & Pancreatic Diseases International
2008
Corpus ID: 25626686
BACKGROUND Cholangiocarcinoma is rare, accounting for approximately 3% of all gastrointestinal cancers. This study aimed to…
Expand
Highly Cited
1996
Highly Cited
1996
A retrospective comparison of endoscopic stenting alone with stenting and radiotherapy in non-resectable cholangiocarcinoma.
T. Bowling
,
S M Galbraith
,
A R Hatfield
,
J. Solano
,
M F Spittle
Gut
1996
Corpus ID: 572882
BACKGROUND AND AIMS: Radiotherapy has been reported to be of benefit in prolonging the survival of patients with…
Expand
1995
1995
Prognostic factors of resectable intrahepatic cholangiocarcinoma
F. Chou
,
S. Sheen-Chen
,
Chao-Long Chen
,
Y. Chen
,
Mao-Chan Chen
Journal of Surgical Oncology
1995
Corpus ID: 7732842
Intrahepatic cholangiocarcinoma is a rare disease. The prognostic factors of resectable cholangiocarcinoma have not been…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE